SCHEMBL19626673

SCHEMBL19626673

Cn1c(=O)c2c(ncn2CC(O)Nc2ccc(N3CCN(C(=O)c4ccc(F)cc4)CC3)cn2)n(C)c1=O

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.58
RXFP1 Q9HBX9 4/20 0.49
L3MBTL1 Q9Y468 2/20 0.47
MAPT P10636 1/20 0.46
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.44
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 2/20 0.42
HTR1A P08908 2/20 0.42
CHRM1 P11229 2/20 0.42
DRD2 P14416 2/20 0.42
ADRA1D P25100 2/20 0.42
ADRA1A P35348 2/20 0.42
ADRA1B P35368 2/20 0.42
GAA P10253 1/20 0.41
TP53 P04637 1/20 0.41
TRPA1 O75762 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20290422 0.88 RAB9A (0.53) RAB9ARXFP1L3MBTL1MAPTTSHR
SCHEMBL21936452 0.87 RAB9A (0.53) RAB9ARXFP1L3MBTL1MAPTTSHR
SCHEMBL17628698 0.87 RAB9A (0.66) RAB9ARXFP1L3MBTL1MAPTTSHR
SCHEMBL21935371 0.83 RAB9A (0.48) RAB9ARXFP1L3MBTL1MAPTTSHR
SCHEMBL20290285 0.83 SMN1; SMN2 (0.50) RAB9ARXFP1L3MBTL1MAPTLMNA
SCHEMBL19997365 0.81 SMN1; SMN2 (0.50) RAB9ARXFP1L3MBTL1MAPTTSHR
SCHEMBL21935370 0.81 RXFP1 (0.60) RAB9ARXFP1L3MBTL1LMNASMN1; SMN2
SCHEMBL21936444 0.79 RAB9A (0.55) RAB9ARXFP1L3MBTL1MAPTMAPK1
SCHEMBL682799 0.79 RXFP1 (0.60) RAB9ARXFP1L3MBTL1TSHRLMNA
SCHEMBL20312670 0.79 RAB9A (0.55) RAB9ARXFP1L3MBTL1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10472360-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-11-12 US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 RAB9A 3162/4885RXFP1 1132/4885L3MBTL1 2626/4885
US-10472360-B2 Purine diones as Wnt pathway modulators WNT1, WNT3A, CTNNB1 RAB9A 3162/4885RXFP1 1132/4885L3MBTL1 2626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.